Bayer Gets in China Its First Global Approval for Stroke Prevention Drug

The decision hands Bayer the first ever approval for a Factor XIa inhibitor, which aim to slow the activity of a protein that regulates how the body forms clots without increasing the risk of bleeding...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。